Cell-free DNA From Pleural Effusion Samples: Is It Right for Molecular Testing in Lung Adenocarcinoma?

Pathogenic molecular features gained specific significance in therapeutic decisions in lung carcinoma in the past decade. Initial and follow up genetic testing requres appropriate amounts and quality of tumor derived DNA, but tumor sampling, especially for disease monitoring is generally limited. Fu...

Descripción completa

Detalles Bibliográficos
Autores principales: Mokánszki, Attila, Bádon, Emese Sarolta, Mónus, Anikó, Tóth, László, Bittner, Nóra, Méhes, Gábor
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Society Journal Archive
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8262152/
https://www.ncbi.nlm.nih.gov/pubmed/34257581
http://dx.doi.org/10.3389/pore.2021.613071

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8262152/
https://www.ncbi.nlm.nih.gov/pubmed/34257581
http://dx.doi.org/10.3389/pore.2021.613071

Ejemplares similares